COSMOS: the dialysis scenario of CKD–MBD in Europe-Reference-Cited by-同舟云学术

COSMOS: the dialysis scenario of CKD–MBD in Europe

Published:2012-11-19 Issue:7 Volume:28 Page:1922-1935
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Fernández-Martín José Luis,Carrero Juan Jesus,Benedik Miha,Bos Willem-Jan,Covic Adrian,Ferreira Aníbal,Floege Jürgen,Goldsmith David,Gorriz José Luis,Ketteler Markus,Kramar Reinhard,Locatelli Francesco,London Gérard,Martin Pierre-Yves,Memmos Dimitrios,Nagy Judit,Naves-Díaz Manuel,Pavlovic Drasko,Rodríguez-García Minerva,Rutkowski Boleslaw,Teplan Vladimir,Tielemans Christian,Verbeelen Dierik,Wüthrich Rudolf P.,Martínez-Camblor Pablo,Cabezas-Rodriguez Iván,Sánchez-Alvarez José Emilio,Cannata-Andia Jorge B.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/28/7/1922/17173108/gfs418.pdf

Reference51 articles.

1. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study;Young;Kidney Int,2005

2. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998

3. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management;Block;Am J Kidney Dis,2000

4. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study;Kimata;Hemodial Int,2007

5. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis;Palmer;JAMA,2011

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs;Expert Opinion on Investigational Drugs;2024-06-19

2. Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients;Nephrology Dialysis Transplantation;2023-09-02

3. The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?;Clinical Kidney Journal;2023-06-27

4. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis;Nephrology Dialysis Transplantation;2023-06-22

5. Distribution, preparedness and management of Ukrainian adult refugees on dialysis—an international survey by the Renal Disaster Relief Task Force of the European Renal Association;Nephrology Dialysis Transplantation;2023-06-16